Sun, Chen <br/><br/>
Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?  [electronic resource] 

 -  World journal of gastroenterology  Sep 2012 
 - 4944-58 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Review 
<br/><br/><label>ISSN: </label>2219-2840 
<br/><br/><label>Standard No.: </label>10.3748/wjg.v18.i35.4944  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Chi-Square Distribution<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Pancreatic Neoplasms--drug therapy<br/>Survival Analysis<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult<br/>Gemcitabine